PALATINI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.806
AS - Asia 4.015
EU - Europa 1.683
AF - Africa 634
SA - Sud America 615
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 28
Totale 15.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.431
SG - Singapore 1.362
CN - Cina 684
VN - Vietnam 495
HK - Hong Kong 439
BR - Brasile 363
DE - Germania 192
IT - Italia 191
FI - Finlandia 186
FR - Francia 157
IN - India 122
BD - Bangladesh 117
UA - Ucraina 103
GB - Regno Unito 94
SE - Svezia 89
PL - Polonia 72
RU - Federazione Russa 69
IQ - Iraq 60
PK - Pakistan 53
NL - Olanda 49
PH - Filippine 48
AR - Argentina 45
SA - Arabia Saudita 43
MX - Messico 41
ID - Indonesia 38
TR - Turchia 37
CO - Colombia 36
CA - Canada 35
AE - Emirati Arabi Uniti 32
UZ - Uzbekistan 31
EG - Egitto 30
TN - Tunisia 30
EC - Ecuador 29
ZA - Sudafrica 28
BE - Belgio 27
KR - Corea 26
PA - Panama 26
SK - Slovacchia (Repubblica Slovacca) 26
RS - Serbia 25
VE - Venezuela 25
ES - Italia 24
MY - Malesia 24
NP - Nepal 24
PT - Portogallo 24
BO - Bolivia 23
CL - Cile 23
CR - Costa Rica 23
ET - Etiopia 23
GT - Guatemala 23
JO - Giordania 23
JP - Giappone 23
LB - Libano 23
PS - Palestinian Territory 23
SN - Senegal 23
IE - Irlanda 22
SI - Slovenia 22
TH - Thailandia 22
TT - Trinidad e Tobago 22
YT - Mayotte 22
KZ - Kazakistan 21
PY - Paraguay 21
AL - Albania 20
AO - Angola 20
DO - Repubblica Dominicana 20
JM - Giamaica 20
KG - Kirghizistan 20
UY - Uruguay 20
YE - Yemen 20
BW - Botswana 19
GR - Grecia 19
IR - Iran 19
LU - Lussemburgo 19
MU - Mauritius 19
SY - Repubblica araba siriana 19
BY - Bielorussia 18
CG - Congo 18
CV - Capo Verde 18
HR - Croazia 18
LY - Libia 18
CH - Svizzera 17
CI - Costa d'Avorio 17
DK - Danimarca 17
GE - Georgia 17
GP - Guadalupe 17
KH - Cambogia 17
MA - Marocco 17
MK - Macedonia 17
ML - Mali 17
NO - Norvegia 17
BB - Barbados 16
CY - Cipro 16
CZ - Repubblica Ceca 16
DJ - Gibuti 16
DZ - Algeria 16
EE - Estonia 16
GF - Guiana Francese 16
MZ - Mozambico 16
AF - Afghanistan, Repubblica islamica di 15
AM - Armenia 15
AZ - Azerbaigian 15
Totale 15.151
Salva come PNG Salva come JPEG
Città #
Singapore 904
Ashburn 883
Fairfield 881
Woodbridge 776
San Jose 752
Ann Arbor 648
Houston 562
Chandler 482
Hong Kong 402
Jacksonville 375
Wilmington 306
Seattle 286
Cambridge 277
Santa Clara 185
Princeton 157
Ho Chi Minh City 151
Boardman 142
Beijing 110
Hanoi 103
San Diego 89
Lauterbourg 87
Roxbury 83
Helsinki 71
Los Angeles 71
Nanjing 65
New York 62
Medford 55
Dong Ket 52
Padova 49
Bytom 46
Des Moines 41
Munich 39
Dallas 37
Guangzhou 32
Shenyang 31
Chicago 30
São Paulo 28
Tashkent 27
Baghdad 26
Orem 26
Panama City 25
Nanchang 24
Dakar 23
Chennai 21
Haiphong 21
Tianjin 21
Amman 20
London 20
Bishkek 19
Frankfurt am Main 19
Guatemala City 19
Jeddah 19
Da Nang 18
Abidjan 17
Bamako 17
Hebei 17
Jinan 17
Phnom Penh 17
San José 17
Addis Ababa 16
Bridgetown 16
Dublin 16
Ljubljana 16
Milan 16
Montevideo 16
Norwalk 16
Luanda 15
Maputo 15
Noumea 15
Athens 14
Bangkok 14
Buffalo 14
Cotonou 14
Kigali 14
Kuala Lumpur 14
Medellín 14
Praia 14
Atlanta 13
Brooklyn 13
Djibouti 13
Gaborone 13
Kingston 13
Kinshasa 13
Luxembourg 13
Managua 13
Niamey 13
Rio de Janeiro 13
Salt Lake City 13
Tokyo 13
Tripoli 13
Yerevan 13
Accra 12
Boston 12
Changsha 12
Conakry 12
Havana 12
Kampala 12
Libreville 12
Mamoudzou 12
Nairobi 12
Totale 10.359
Salva come PNG Salva come JPEG
Nome #
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes 380
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 322
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 312
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. 262
Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat. 258
Expression and distribution of the adrenomedullin system in newborn human thymus. 245
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes 244
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells 232
Biological and pharmacological properties of phospholipids. 231
A comparison between different methods for the determination of reduced and oxidized glutathione in mammalian tissues 228
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 214
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 213
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 211
Pharmacokinetic drug interactions in liver disease: An update 209
Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin. 208
Coadministration of sirolimus alters tacrolimus pharmacokinetics. 206
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 204
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 204
Penetration of carumonam into the pleural fluid: comparison of intravenous bolus and constant infusion in rats with experimentally induced pleurisy. 203
Further purification and characterization of the succinyl-CoA:3-hydroxy-3-methylglutarate coenzyme A transferase from rat-liver mitochondria. 201
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 197
Enzyme inhibition and induction in liver disease. 194
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 194
Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells 192
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 190
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats. 190
Pharmacokinetic characterization of phosphatidylserine liposomes in the rat 184
In vitro inhibition of cytochrome P450 (CYP) 2C8-mediated drug metabolism by the flavonoid diosmetin 184
A reassessment of the optimal sampling time for the MEGX liver function test 184
A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers 183
Renal clearance of N-1-Methylnicotinamide is a marker of liver dysfunction in cirrhosis 182
Enzyme induction is independent on liver functional status 178
Synergism between lysophosphatidylserine and the phorbol ester tetradecanoylphorbolacetate in rat mast cells. 177
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 174
The role of residual phospholipids and copurified proteins in the reconstitution of bovine heart mitochondrial ATPase complex. 174
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 172
Disposition kinetics of phospholipid liposomes. 170
Effects of single dose of gamma-hydroxybutyric acid and lorazepam in psychomotor performance and subjective feelings in healthy volunteers 168
Reactivation of a phospholipid-depleted sodium, potassium-stimulated ATPase 167
Mechanism of local anesthetic effect. Involvement of F0 in the inhibition of mitochondrial ATP synthase by phenothiazines. 167
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin 166
The effect of age on plasma MEGX concentrations. 165
Canrenone as a partial agonist at the digitalis receptor site of (Na+-K+)ATPase 164
F1-ATPase from different submitochondrial particles. 164
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 164
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 163
The pharmacokinetics of teniloxazine in healthy subjects and patients with liver cirrhosis 160
Role of antioxidant defences in the species-specific response of isolated atria to menadione 160
Neoral versus Sandimmun in kidney-pancreas transplantation 160
Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. 157
Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats. 156
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity 155
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 151
Effect of gender on the monoethylglycinexylidide test in healthy subjects and patients with liver cirrhosis 150
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 149
The interaction of tricyclic antipsychotics with (Na+-K+)ATPase 149
Pharmacokinetics of miocamycin in patients with liver cirrhosis. 148
Mg-dependent inhibition of beef heart soluble mitochondrial ATPase by tricyclic antipsychotics 148
Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria 147
Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers. 147
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis - Phase I study 147
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. 146
A new plot for multiple enzyme inhibition 145
Mechanism of local anesthetic effect on mitochondrial ATP synthase as deduced from photolabelling and inhibition studies with phenothiazine derivatives. 145
EFFECTS OF HERPES-SIMPLEX VIRUS TYPE-1 INFECTION ON THE PLASMA- MEMBRANE AND RELATED FUNCTIONS OF HELA S3 CELLS 142
Apomorphine-induced inhibition of histamine release in rat peritoneal mast cells. 141
Anion activation of dopamine beta-hydroxylase: a kinetic model. 140
A simple method for discriminating between full and partial inhibitors 139
Nephrotoxic effect of Atractyloside in rats 138
Role of phosphatidylserine and phosphatidylcholine in the dicyclohexylcarbodiimide-induced inhibition of mitochondrial ATPase 137
Reversal by phospholipids of the oligomycin induced inhibition of membrane associated adenosintriphosphatases 137
Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis 136
Inhibition of protein kinase activity by apomorphine. 134
Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics 133
Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications? 133
Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase. 133
[Function of phospholipids in a membranous in a membranous complex with ATPase activity]. 130
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 128
The interaction between full and partial inhibitors acting on a single enzyme: a theoretical analysis 119
Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test. 119
Effect of experimentally induced liver cirrhosis on CYP3A induction in male Wistar rats 118
Stereospecific disposition of flunoxaprofen enantiomers in human beings. 115
Serine phospholipids as endocoids. 112
Differential effect of liver dysfunction on CYP3A1 and CYP3A2 expression in rats with carbon tetrachloride-induced cirrhosis 111
Inhibition of dopamine beta-hydroxylase by captopril. 110
Evaluation ciprofloxacin and ofloxacin pharmacokinetics in liver cirrhosis. 105
ORAL DISPOSITION KINETICS OF N-(AMINOSULPHONYL)-3-(((DIAMINOETHYLENE) AMINO)-N-THIAZOLYL) METHYLTHIOPROPANIMIDAMIDE (FAMOTIDINE) IN PATIENTS WITH LIVER-CIRRHOSIS 104
Pharmacokinetic interactions between Tacrolimus and Sirolimus in Kidney Transplant recipients 103
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid 99
Interazioni farmacocinetiche tra Tacrolimus e Sirolimus nel Trapianto Renale 99
Pharmacokinetics of gamma hydroxybutyric acid. 95
Effect of CYP 3A4 inhibition on lidocaine kinetics and the MEGS liver function test 94
The behaviour of miocamycin kinetics in cirrhotic patients after single and repeated oral administration. 93
Effect of liver functional status on the pharmacokinetic interaction between the CYP 1A2 inhibitor fluvoxamine and lidocaine 87
Famotidine pharmacokinetics in the elderly: results of a preliminary study 86
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 75
Totale 15.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.439
article - articoli 42.010
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 242
Totale 87.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 35 124 138 87 29 77 48 124 42 36 130 262
2022/2023951 177 132 11 103 166 137 10 59 108 6 30 12
2023/2024326 22 57 36 32 18 30 8 22 6 2 47 46
2024/20251.758 3 146 71 70 293 44 47 119 160 73 307 425
2025/20266.877 200 567 914 1.091 583 314 859 672 811 381 257 228
2026/2027340 340 0 0 0 0 0 0 0 0 0 0 0
Totale 15.859